Background and Aims:
Hemodynamic changes to pneumoperitoneum and postoperative pain can be detrimental in obese patients; we investigated whether intravenous (IV) or intraperitoneal (IP) magnesium sulphate (MgSo
4
) administration could attenuate the hemodynamic stress response to pneumoperitoneum and improve postoperative pain control after laparoscopic sleeve gastrectomy (LSG).
Material and Methods:
In total, 120 patients scheduled for LSG were randomized to either, control group (Group C, IV and IP saline), Group I (IV 30 mg/kg MgSo
4
), or Group
P
(IP 30 mg/kg MgSo
4
). Outcome variables were mean arterial pressure (MAP), heart rate (HR), postoperative pain score, total analgesic consumption, and incidence of adverse events.
Results:
MAP and HR were significantly lower in Groups I and
P
than that in control group. Pain score was better in Groups I and
P
than in control group up to 2 h postoperative (
P
= 0.023, 0.010, respectively); it was significantly lower in Group
P
than other two groups at 4 h postoperative (
P
<0.001). Significantly, reduced postoperative analgesic consumption with delayed onset to first analgesic request were observed in magnesium groups compared to control (
P
= 0.001, respectively). Moreover, onset to first analgesic request was longer in Group
P
than Group I (
P
= 0.001). No serious side effects were noticed.
Conclusion:
The IV and IP administration of MgSo
4
significantly attenuated the circulatory response to pneumoperitoneum and reduced postoperative pain as well as opioid consumption as compared to controls in obese patients undergoing LSG with no serious adverse effects.